Clinical and Molecular Characteristics of Histiocytic Disorders
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06331377
- Status
- Recruiting
Conditions
- Histiocytic Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Year - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Non-Interventional Study — OTHERNon-interventional study
Study Details
This study is being done to collect medical and personal histories as well as a samples of blood, other body fluid and/or tumor/disease tissue for current and future research studies on histiocytic disorders.
Key Dates
- Start date
- Jul 27, 2017
- Status verified
- Sep 2025
- Primary completion
- Jul 31, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 500 participants (estimated)
Arms
- Arm: ObservationalPatients complete questionnaires and undergo blood and tissue sample collection. Patients' medical records are also reviewed.
Primary Outcome Measure
Identify molecular markers [ Time Frame: Baseline ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | Ronald S. Go, M.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
By research site